Close
Digital Health & Ai Innovation summit 2026
Medica Compamed 2026

Zoll Medical announced Zoll LifeVest Wearable Defibrillator is now covered by Medical Assistance(MA)

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Plans Approved for $1.4bn Bankstown Hospital...

Australia's New South Wales Government has confirmed planning approval...

ARPA-H Awards Siemens Healthineers $31.1 Million...

The Advanced Research Projects Agency for Health (ARPA-H) has...

Haemonetics Reconnects with CSL in US...

Haemonetics is set to supply CSL Plasma with its...
ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, announced that the ZOLL LifeVest® Wearable Defibrillator is now covered by Medical Assistance (MA), Minnesota’s Medicaid program.

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, announced that the ZOLL LifeVest® Wearable Defibrillator is now covered by Medical Assistance (MA), Minnesota’s Medicaid program. MA is the largest of the state’s health care programs, providing health care coverage and prescription coverage to a monthly average of 507,000 low-income senior citizens, children and families, and people with disabilities.    

LifeVest is typically worn for two to three months by patients at risk for sudden cardiac arrest (SCA), either while the decision is made to implant a cardiac defibrillator (ICD) or when an ICD may not be appropriate for the patient.  This 1.8 pound device is a vest with electrodes that is connected to a “walkman-sized” defibrillator worn on a belt.  It provides constant monitoring of the patient’s heart, immediate protection, and peace of mind, as it records data to help diagnose and treat life-threatening arrhythmias.

Richard A. Packer, President and Chief Executive Officer of ZOLL siad, Having the LifeVest now approved in Minnesota is another important step in bringing this technology to more patients.  As with many other potential life-saving treatments, it takes insurance coverage to make them accessible to more people who could benefit from them.

The LifeVest is specifically approved by Medicare and other insurers for those at high risk of cardiac arrest who can’t have immediate implant surgery for an ICD (implantable cardioverter defibrillator), including those recovering from infections.  

Never miss a healthcare headline

Healthcare moves fast – stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

Plans Approved for $1.4bn Bankstown Hospital Development in Sydney

Australia's New South Wales Government has confirmed planning approval...

Haemonetics Reconnects with CSL in US Plasma Collection Deal

Haemonetics is set to supply CSL Plasma with its...

Norton Healthcare Launches $30 Million High-Tech Automated Pharmacy Hub

Norton Healthcare has officially opened a new $30 million...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »